Antitumor efficacy and tumor-selective replication with a single intravenous injection of OAS403, an oncolytic adenovirus dependent on two prevalent alterations in human cancer (Q47251747)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Antitumor efficacy and tumor-selective replication with a single intravenous injection of OAS403, an oncolytic adenovirus dependent on two prevalent alterations in human cancer	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

12 January 2018

http://europepmc.org/abstract/MED/15232601

Antitumor efficacy and tumor-selective replication with a single intravenous injection of OAS403, an oncolytic adenovirus dependent on two prevalent alterations in human cancer (English)

1 reference

Europe PubMed Central

12 January 2018

http://europepmc.org/abstract/MED/15232601

oncolytic virus

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Patricia C Ryan

1

1 reference

Europe PubMed Central

12 January 2018

http://europepmc.org/abstract/MED/15232601

John L Jakubczak

2

1 reference

Europe PubMed Central

12 January 2018

http://europepmc.org/abstract/MED/15232601

David A Stewart

3

1 reference

Europe PubMed Central

12 January 2018

http://europepmc.org/abstract/MED/15232601

Lynda K Hawkins

4

1 reference

Europe PubMed Central

12 January 2018

http://europepmc.org/abstract/MED/15232601

Cheng Cheng

5

1 reference

Europe PubMed Central

12 January 2018

http://europepmc.org/abstract/MED/15232601

Lori M Clarke

6

1 reference

Europe PubMed Central

12 January 2018

http://europepmc.org/abstract/MED/15232601

Shanthi Ganesh

7

1 reference

Europe PubMed Central

12 January 2018

http://europepmc.org/abstract/MED/15232601

Carl Hay

8

1 reference

Europe PubMed Central

12 January 2018

http://europepmc.org/abstract/MED/15232601

Ying Huang

9

1 reference

Europe PubMed Central

12 January 2018

http://europepmc.org/abstract/MED/15232601

Michele Kaloss

10

1 reference

Europe PubMed Central

12 January 2018

http://europepmc.org/abstract/MED/15232601

Anthony Marinov

11

1 reference

Europe PubMed Central

12 January 2018

http://europepmc.org/abstract/MED/15232601

Sandrina S Phipps

12

1 reference

Europe PubMed Central

12 January 2018

http://europepmc.org/abstract/MED/15232601

P Seshidhar Reddy

13

1 reference

Europe PubMed Central

12 January 2018

http://europepmc.org/abstract/MED/15232601

Pamela S Shirley

14

1 reference

Europe PubMed Central

12 January 2018

http://europepmc.org/abstract/MED/15232601

Yelena Skripchenko

15

1 reference

Europe PubMed Central

12 January 2018

http://europepmc.org/abstract/MED/15232601

Ling Xu

16

1 reference

Europe PubMed Central

12 January 2018

http://europepmc.org/abstract/MED/15232601

Jingping Yang

17

1 reference

Europe PubMed Central

12 January 2018

http://europepmc.org/abstract/MED/15232601

Suzanne Forry-Schaudies

18

1 reference

Europe PubMed Central

12 January 2018

http://europepmc.org/abstract/MED/15232601

Paul L Hallenbeck

19

1 reference

Europe PubMed Central

12 January 2018

http://europepmc.org/abstract/MED/15232601

publication date

1 August 2004

1 reference

Europe PubMed Central

12 January 2018

http://europepmc.org/abstract/MED/15232601

Cancer Gene Therapy

1 reference

Europe PubMed Central

12 January 2018

http://europepmc.org/abstract/MED/15232601

11

1 reference

Europe PubMed Central

12 January 2018

http://europepmc.org/abstract/MED/15232601

555-569

1 reference

Europe PubMed Central

12 January 2018

http://europepmc.org/abstract/MED/15232601

8

1 reference

Europe PubMed Central

12 January 2018

http://europepmc.org/abstract/MED/15232601

https://scigraph.springernature.com/pub.10.1038/sj.cgt.7700735

0 references

Replicative adenoviruses for cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700735

21 January 2018

A novel tumor-specific replication-restricted adenoviral vector for gene therapy of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700735

21 January 2018

Oncolytic biotherapy: a novel therapeutic plafform

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700735

21 January 2018

Selectivity of a replication-competent adenovirus for human breast carcinoma cells expressing the MUC1 antigen.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700735

21 January 2018

a controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700735

21 January 2018

Replication-selective virotherapy for cancer: Biological principles, risk management and future directions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700735

21 January 2018

Phase II trial of intratumoral administration of ONYX-015, a replication-selective adenovirus, in patients with refractory head and neck cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700735

21 January 2018

Adenovirus early E4 genes in viral oncogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700735

21 January 2018

Sibling rivalry in the E2F family

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700735

21 January 2018

The regulation of E2F by pRB-family proteins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700735

21 January 2018

Transcriptional control by E2F.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700735

21 January 2018

Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700735

21 January 2018

hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700735

21 January 2018

Expression of TERT in early premalignant lesions and a subset of cells in normal tissues.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700735

21 January 2018

Activity, function, and gene regulation of the catalytic subunit of telomerase (hTERT)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700735

21 January 2018

Caspase-8 gene therapy using the human telomerase reverse transcriptase promoter for malignant glioma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700735

21 January 2018

The telomerase reverse transcriptase promoter drives efficacious tumor suicide gene therapy while preventing hepatotoxicity encountered with constitutive promoters

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700735

21 January 2018

Ad-mTERT-delta19, a conditional replication-competent adenovirus driven by the human telomerase promoter, selectively replicates in and elicits cytopathic effect in a cancer cell-specific manner

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700735

21 January 2018

Telomerase-dependent oncolytic adenovirus for cancer treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700735

21 January 2018

Conditionally replicative adenovirus driven by the human telomerase promoter provides broad-spectrum antitumor activity without liver toxicity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700735

21 January 2018

Alterations of the RB tumour suppressor gene in hepatocellular carcinoma and hepatoblastoma cell lines in association with abnormal p53 expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700735

21 January 2018

Suppression of growth in vitro and tumorigenicity in vivo of human carcinoma cell lines by transfected p16INK4.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700735

21 January 2018

LNCaP progression model of human prostate cancer: androgen-independence and osseous metastasis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700735

21 January 2018

A simplified system for generating recombinant adenoviruses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700735

21 January 2018

Adenovirus type 5 viral particles pseudotyped with mutagenized fiber proteins show diminished infectivity of coxsackie B-adenovirus receptor-bearing cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700735

21 January 2018

In vivo hepatic adenoviral gene delivery occurs independently of the coxsackievirus-adenovirus receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700735

21 January 2018

Evaluation of the biodistribution, persistence, toxicity, and potential of germ-line transmission of a replication-competent human adenovirus following intraprostatic administration in the mouse

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700735

21 January 2018

Tumor-selective transgene expression in vivo mediated by an E2F-responsive adenoviral vector.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700735

21 January 2018

Adenovirus and intranuclear inclusions in appendices in intussusception

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700735

21 January 2018

Expression of mouse telomerase reverse transcriptase during development, differentiation and proliferation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700735

21 January 2018

NF-kappa B regulates transcription of the mouse telomerase catalytic subunit

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700735

21 January 2018

Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700735

21 January 2018

In vivo dose threshold effect of adenovirus-mediated factor VIII gene therapy in hemophiliac mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700735

21 January 2018

Sequestration of adenoviral vector by Kupffer cells leads to a nonlinear dose response of transduction in liver

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700735

21 January 2018

E1B-deleted adenovirus (dl1520) gene therapy for patients with primary and secondary liver tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700735

21 January 2018

Update on adenovirus and its vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700735

7 January 2021

based on heuristic

inferred from DOI database lookup

Generation of an adenovirus vector lacking E1, e2a, E3, and all of E4 except open reading frame 3.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700735

7 January 2021

based on heuristic

inferred from DOI database lookup

Adenovirus early region 4 encodes functions required for efficient DNA replication, late gene expression, and host cell shutoff

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700735

7 January 2021

based on heuristic

inferred from DOI database lookup

Cell cycle-regulated transcription in mammalian cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700735

7 January 2021

based on heuristic

inferred from DOI database lookup

Induced apoptosis supports spread of adenovirus vectors in tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700735

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.CGT.7700735

1 reference

Europe PubMed Central

12 January 2018

http://europepmc.org/abstract/MED/15232601

1 reference

Europe PubMed Central

12 January 2018

http://europepmc.org/abstract/MED/15232601

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47251747&oldid=2148001618"